|Bid||150.00 x 800|
|Ask||207.00 x 1200|
|Day's Range||192.50 - 208.36|
|52 Week Range||98.37 - 212.62|
|Beta (5Y Monthly)||0.49|
|PE Ratio (TTM)||22.97|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Specialty pharmaceutical-company United Therapeutics (NASDAQ: UTHR) was an outlier stock in the best way on Wednesday. After reporting quarterly figures showing revenue growth in all of its products, the shares closed the day over 14% higher. United Therapeutics took in $446.5 million in revenue for its Q2, which was a very healthy 23% higher year over year.
Image source: The Motley Fool. United Therapeutics Corporation (NASDAQ: UTHR)Q2 2021 Earnings CallAug 4, 2021, 9:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning and welcome to the United Therapeutics Corporation's Second Quarter 2021 Earnings Webcast.
United Therapeutics (UTHR) delivered earnings and revenue surprises of 27.62% and 17.66%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?